- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
IBM's Watson Impacts All Aspects of Discovery Research
Improved cognitive computing by the supercomputer has accelerated the pace of scientific breakthroughs by discovering previously unknown connections in Big Data.
Available now as a cloud service, IBM's Watson Discovery Advisor is designed to scale and accelerate discoveries by research teams. It reduces the time needed to test hypotheses and formulate conclusions that can advance their work -- from months to days and days to just hours -- bringing new levels of speed and precision to research and development.
Building on Watson's ability to understand nuances in natural language, Watson Discovery Advisor can understand the language of science, such as how chemical compounds interact, making it a uniquely powerful tool for researchers in life sciences and other industries.
Researchers and scientists from leading academic, pharmaceutical and other commercial research centers have begun deploying IBM's new Watson Discovery Advisor to rapidly analyze and test hypotheses using data in millions of scientific papers available in public databases. A new scientific research paper is published nearly every 30 seconds, which equals more than a million annually (Source: CiteSeerx). According to the National Institutes of Health, a typical researcher reads about 23 scientific papers per month, which translates to nearly 300 per year, making it humanly impossible to keep up with the ever-growing body of scientific material available.
Read the complete press release here: http://ibm.co/1qkenMp
Source: IBM
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
